top of page
    Search

    ICM HPQC Fund: Neuromorphic Computing

    • ICM
    • Aug 28, 2025
    • 2 min read

    At the ICM HPQC Fund we seek out early-stage investments in technologies that can radically improve the way compute can be generated and delivered.


    Beyond High Performance Classical Data Centres, AI, LLMs Nvidia, and even quantum computing is an area that we are increasingly interested in – remember the HPQC Fund loves breakthrough technologies but only invests when those technologies are ready to scale commercially. We may be close to that tipping point with Neuromorphic Computing

    Written by the Chair of our Technical Advisory Board, Dr Bill Jefferies, the following paper provides an introduction for LP clients, an overview of the sector, and a framework for our ongoing communication on this topic with you.


    Dr William "Bill" Jeffrey has worked with emerging technologies for 30+ years, driving the development of groundbreaking products and bringing innovations from the lab to the marketplace, including as Director of NIST and as CEO of HRL and SRI International. Bill is a director of unlisted and listed technology companies internationally.







    Access the full Neuromorphic Computing paper here.




    The information in this article should not be considered an offer or solicitation to deal in ICM HPQC Fund (Registration number T22VC0112B-SF003) (the “Sub-fund”). The information is provided on a general basis for informational purposes only and is not to be relied upon as investment, legal, tax, or other advice. It does not take into account the investment objectives, financial situation, or particular needs of any specific investor. The information presented has been obtained from sources believed to be reliable, but no representation or warranty is given or may be implied that it is accurate or complete. The Investment Manager reserves the right to amend the information contained herein at any time, without notice. Investments in the Sub-fund are subject to investment risks, including the possible loss of the principal amount invested. The value of investments and the income derived therefrom may fall or rise. Past performance is not indicative of future performance. Investors should seek relevant professional advice before making any investment decision. This document is intended solely for institutional investors and accredited investors as defined under the Securities and Futures Act (Cap. 289) of Singapore. This document has not been reviewed by the Monetary Authority of Singapore.


    ICM HPQC Fund is a registered Sub-Fund of the ICMGF VCC (the VCC), a variable capital company incorporated in the Republic of Singapore. The assets and liabilities of ICM HPQC Fund are segregated from other Sub-Funds of the VCC, in accordance with Section 29 of the VCC Act. 

    Comments


    © 2026 by ICM Global Funds Pte. Ltd. All rights reserved.


    All investments carry risks, including the risk of loss of capital, and may not be suitable for everyone. The information on this website is solely for information purposes and is not intended to be, and should be construed as, an offer or recommendation to buy or sell investments. If you are in any doubt as to the appropriate course of action, you should consult your own independent tax/financial adviser, stockbroker, solicitor, accountant or other professional adviser. 


    Past performance is not necessarily indicative of the future performance. Investment return and principal value will fluctuate, and investors may not get back the full amount they originally invested. The information contained herein has been obtained from sources believed to be reliable; however, no representation or warranty is given to the current accuracy, completeness or reliability, and ICM Global Funds Pte. Ltd. accepts no liability for decisions based on such information.

    This advertisement has not been reviewed by the Monetary Authority of Singapore.

    bottom of page